Search results for "Opioids"
Opioid manufacturers told to develop physician, patient education
As part of a new federal effort to reduce prescription drug abuse in the U.S., the FDA will begin requiring a Risk Evaluation and Mitigation Strategy (REMS) for all extended-release and long-acting opioid medications.
https://immattersacp.org/weekly/archives/2011/04/26/6.htm
26 Apr 2011
For arthritis, opioids present increased relative risk compared to NSAIDs
Cystatin C beats creatinine at predicting complications of kidney disease
https://immattersacp.org/weekly/archives/2010/12/21/4.htm
21 Dec 2010
ACP's Pain Management Learning Hub releases new learning materials
Each of the new peer-to-peer activities provides opportunities for ACP members to earn free CME/MOC credit and meet many state-based CME requirements.
https://immattersacp.org/weekly/archives/2022/02/01/6.htm
1 Feb 2022
Illicitly manufactured fentanyls involved in increasing number of U.S. overdose deaths
From July 2019 to December 2020, sharp increases were seen in deaths involving illicitly manufactured fentanyls in midwestern (33.1%), southern (64.7%), and western (93.9%) jurisdictions, federal data indicate.
https://immattersacp.org/weekly/archives/2021/12/21/4.htm
21 Dec 2021
MKSAP Quiz: Evaluation for confusion
A 63-year-old man is evaluated in the ED for confusion. He recently visited an urgent care center for symptoms of an upper respiratory tract infection and was prescribed codeine-guaifenesin. Following a physical exam and administration of naloxone, what is the most likely cause of this patient's adverse drug reaction?
https://immattersacp.org/weekly/archives/2022/12/06/4.htm
6 Dec 2022
MKSAP Quiz: Evaluation for low back pain
A 47-year-old man is evaluated for low back pain. The pain began 5 days ago while he was playing basketball. It is localized to the lumbar back and does not radiate. The patient is unable to sit or stand for long periods, but the pain improves when lying down. After a physical exam, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2022/05/17/4.htm
17 May 2022
‘Gold standard’ underused for substance misuse
While effective medications to treat opioid addiction are available in primary care, few physicians prescribe buprenorphine or naltrexone, and few would obtain the Drug Enforcement Administration (DEA) waiver to prescribe buprenorphine.
https://immattersacp.org/archives/2020/11/gold-standard-underused-for-substance-misuse.htm
1 Nov 2020
Treatment pathways compared for diabetic peripheral neuropathy
Amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin were similarly effective for controlling pain, a recent study found.
https://immattersacp.org/weekly/archives/2022/08/30/2.htm
30 Aug 2022
States step in on opioid prescribing
This issue covers such topics as legislative issues regarding prescribing, potential overdoses by patients taking narcotics, and a new way to look at overall health.
https://immattersacp.org/archives/2016/10/editors.htm
1 Oct 2016
Extended-release morphine didn't improve breathlessness in COPD
Patients with chronic obstructive pulmonary disease (COPD) randomized to two different doses of morphine or placebo for three weeks reported similar effects on breathlessness, an Australian trial found. Their step count also didn't change.
https://immattersacp.org/weekly/archives/2022/11/29/1.htm
29 Nov 2022